N2-Tritylolmesartan medoxomil (CAS No: 1020157-01-0) is a key pharmaceutical intermediate used in the synthesis of APIs Olmesartan. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: N2-Trityl olmesartan medoxomil,N2-Tritylolmesartan medoxomil
CAS No: 1020157-01-0
PubChem CID: 10700531
Mol Formula: C48H44N6O6
Mol Weight: 800.9 g/mol
Used in API: Olmesartan
IUPAC Name: (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
API Intermediate Description: N²-Tritylolmesartan medoxomil is a protected, late-stage pharmaceutical intermediate used in the industrial synthesis of olmesartan medoxomil. It is not a finished drug and has zero standalone therapeutic relevance. Its sole purpose is process control—specifically selective protection of the N² position during multi-step synthesis.
